Ballew Advisors, Inc Bristol Myers Squibb CO Transaction History

Ballew Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $26,964 - $34,966	-553 Closed	0 $0
Q3 2018 Oct 30, 2018	SELL	$55.19 - $62.25 $5,463 - $6,162	-99 Reduced 15.18%	553 $28,000
Q2 2018 Jul 30, 2018	BUY	$50.53 - $62.98 $6,417 - $7,998	127 Added 24.19%	652 $36,000
Q1 2018 May 07, 2018	BUY	$59.92 - $68.98 $31,458 - $36,214	525 New	525 $33,000

2,557

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86.9B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ballew Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ballew Advisors, Inc with notifications on news.